- Artemotil
-
- $50.00 / 20mg
-
2025-10-31
- CAS:75887-54-6
- Min. Order:
- Purity: 99.88%
- Supply Ability: 10g
- Arteether
-
- $0.00 / 25Kg/Drum
-
2025-10-31
- CAS:75887-54-6
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 1000kg
- Arteether
-
- $0.00 / 1kg
-
2025-10-31
- CAS:75887-54-6
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 1000kg
|
| | Arteether Basic information |
| Product Name: | Arteether | | Synonyms: | Arteether;ARPRINOCID;SM-227;dihydroartemisinin ethyl ether;dihydroqinghaosu ethyl ether;(3R,12aR)-3,6α,9β-Trimethyl-10β-ethoxy-3β,12α-epoxy-3,4,5,5aα,6,7,8,8aα,9,10-decahydropyrano[4,3-j]-1,2-benzodioxepin;3,12-Epoxy-12H-pyrano(4,3-J)-1,2-benzodioxepin, 10-ethoxydecahydro-3,6,9-trimethyl-, (3S-(3alpha,5alpha,6alpha,8aalpha,9beta,10beta,12beta,12aalpha))-;AlphaBetaArteetherC17H28O5 | | CAS: | 75887-54-6 | | MF: | C17H28O5 | | MW: | 312.4 | | EINECS: | | | Product Categories: | Chiral Reagents;Heterocycles;Antimalarial;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 75887-54-6.mol |  |
| | Arteether Chemical Properties |
| Melting point | 80-820C | | alpha | D21 +154.5° (c = 1.0 in CHCl3) | | Boiling point | 372.4±42.0 °C(Predicted) | | density | 1.16±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,2-8°C | | solubility | Chloroform (Slightly), Ethyl Acetate (Slightly) | | form | Solid | | color | White | | Optical Rotation | [α]/D +148 to +165°, c =1 in chloroform-d | | InChI | InChI=1S/C17H28O5/c1-5-18-14-11(3)13-7-6-10(2)12-8-9-16(4)20-15(19-14)17(12,13)22-21-16/h10-15H,5-9H2,1-4H3/t10-,11-,12+,13+,14+,15-,16-,17-/m1/s1 | | InChIKey | NLYNIRQVMRLPIQ-XQLAAWPRSA-N | | SMILES | O1[C@]23[C@@]4([H])O[C@@](C)(CC[C@@]2([H])[C@H](C)CC[C@@]3([H])[C@@H](C)[C@@H](OCC)O4)O1 | | CAS DataBase Reference | 75887-54-6 |
| | Arteether Usage And Synthesis |
| Description | Arteether reached the market in the Netherlands as a solution in sesame oil,
administered by i.m. injection, for the treatment of severe malaria infections in children and
adolescents. Artheether, a sesquiterpene acetal with an endoperoxide bridge, is an ether
derivative of the naturally occuring compound artemisinin, the active component of
Chinese herbal remedies. As the other structural analogs of artemisinin, such as
artesunate or artemether, it acts rapidly against Plasmodium, the parasite responsible for
the disease, during the early blood stage of its development. It also exhibits a
gametocytocidal activity against Plasmodium falciparum, reducing its potential for
transmission. Because the only controlled clinical studies had been performed in children
and adolescents, this new antimalarial drug was only approved for young patients. Further
studies in adults treated with 150 mg i.m. artemotil, once daily for three consecutive days,
indicated that the drug was efficient, rapidly acting (parasite clearance time meanly 38 h)
and well tolerated. A new promising achievement in the regression of malaria is the
combination of artemisinin derivatives with other long-lived antimalarials as mefloquine or
pyrimethamine/sulfa. | | Chemical Properties | White Crystalline Solid | | Originator | Central Drug Research Institute (India) | | Uses | Derivative of Artemisinin. Antimalarial | | Definition | ChEBI: Artemotil is an artemisinin derivative. | | Brand name | Artemotil | | Synthesis | The general procedure for the synthesis of (3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-ethoxy-3,6,9-trimethyldecahydro-3H-3,12-epoxy[1,2]dioxepino[4,3-i]isobenzofuran from artemisinin (CAS: 108739-44-2) was as follows:
Example 1: Artemisinin (1.0 g) was dissolved in ethanol (20 mL) with polyhydroxy catalyst dextrose (5.0 g) and stirred at room temperature for 5 minutes. Subsequently, sodium borohydride (600 mg) was slowly added over 10 min and the reaction mixture was stirred for about 1 h at room temperature (20-23°C). The progress of the reaction was monitored by thin layer chromatography (TLC) to confirm the completion of the reduction step. The acid catalyst chlorotrimethylsilane (3.5 mL) was slowly added at 10-23°C. The reaction mixture was continued to be stirred at room temperature for about 1 hour. Upon completion of the reaction, cooling water (about 150 mL) was added to the mixture and the aqueous phase was extracted with a hexane solution of 1% ethyl acetate (3 x 50 mL). The combined ethyl acetate-hexane extract was washed sequentially with 0.5% sodium bicarbonate solution (100 mL) and water (50 mL). The hexane extract was dried over anhydrous sodium sulfate and the solvent was evaporated to give 1.038 g of the crude product, which contained artemether and a few impurities. The crude product was purified by silica gel column chromatography (silica gel 10 g, eluent 0.5% to 8% ethyl acetate in hexane solution) to give a mixture of α and β arteether 0.86 g (yield 86% w/w). A small amount of arteether was taken to separate the α and β isomers by preparative thin layer chromatography (TLC) and characterized by co-thin layer chromatography (Co-TLC) and spectral analysis. | | References | [1] Patent: US2004/106809, 2004, A1. Location in patent: Page 3 [2] Patent: US2004/106809, 2004, A1. Location in patent: Page 4 [3] Patent: US2004/106809, 2004, A1. Location in patent: Page 3-4 |
| | Arteether Preparation Products And Raw materials |
| Raw materials | anhydrodihydroartemisinin-->Artemisinin-->DHQHS 2-->Naphtho[1,2-b]furan-2,8(3H,4H)-dione, 3a,5,5a,6,7,9b-hexahydro-4-hydroxy-3,5a,9-trimethyl-, (3S,3aR,4S,5aR,9bS)--->ARTEMISIN-->alpha-Dihydroartemisinin-->Ethanol-->Triethyl orthoformate | | Preparation Products | (3R,12aR)-3,6α,9β-Trimethyl-3β,12α-epoxy-3,4,5,5aα,6,7,8,8aα,9,10-decahydro-10α-ethoxypyrano[4,3-j]-1,2-benzodioxepin-->Deoxy Arteether |
|